| value |
{"aggregator_url":"https://news.google {"aggregator_url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOOGg4SXJqYThOR0hpdzA1WG1sUDJzNXFSRTk5MXlkTmRxclEzTUNKaTJDYjVIeGxKV0FqMEJ6bWIwSjFyM1YweEw1MldZN1NvN0NoUnk3MWpvUlpLX1RuTDlaLWkydlgxRjRMVmdrSEVIZXlXcmtRXzRkWVZXdk0tdlpoTjVMSnZuZzFPT1VqM2VTTHU3NC1Tbg?oc=5","as_of":"2026-04-09T15:51:37.571743+00:00","canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp","enrichment":{"aggregator_url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOOGg4SXJqYThOR0hpdzA1WG1sUDJzNXFSRTk5MXlkTmRxclEzTUNKaTJDYjVIeGxKV0FqMEJ6bWIwSjFyM1YweEw1MldZN1NvN0NoUnk3MWpvUlpLX1RuTDlaLWkydlgxRjRMVmdrSEVIZXlXcmtRXzRkWVZXdk0tdlpoTjVMSnZuZzFPT1VqM2VTTHU3NC1Tbg?oc=5","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_a24bbfbbd60c319c","canonical_host":"gstatic.com","canonical_is_aggregator":true,"canonical_url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-09T23:44:21.204491+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOOGg4SXJqYThOR0hpdzA1WG1sUDJzNXFSRTk5MXlkTmRxclEzTUNKaTJDYjVIeGxKV0FqMEJ6bWIwSjFyM1YweEw1MldZN1NvN0NoUnk3MWpvUlpLX1RuTDlaLWkydlgxRjRMVmdrSEVIZXlXcmtRXzRkWVZXdk0tdlpoTjVMSnZuZzFPT1VqM2VTTHU3NC1Tbg?oc=5&hl=en-US&gl=US&ceid=US:en","html_truncated":true,"paywall_likely":false,"publisher_domain":"theguardian.com","publisher_resolution":"payload_source_domain","requested_url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOOGg4SXJqYThOR0hpdzA1WG1sUDJzNXFSRTk5MXlkTmRxclEzTUNKaTJDYjVIeGxKV0FqMEJ6bWIwSjFyM1YweEw1MldZN1NvN0NoUnk3MWpvUlpLX1RuTDlaLWkydlgxRjRMVmdrSEVIZXlXcmtRXzRkWVZXdk0tdlpoTjVMSnZuZzFPT1VqM2VTTHU3NC1Tbg?oc=5","source_event_id":"evt_3baf1cb76613","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"fp":"cb64d68f953c5814","published_at":"2026-04-09T15:00:00+00:00","publisher_domain":"theguardian.com","signal_understanding":{"analysis_basis":"headline_and_summary","claim_confidence":0.55,"dates_mentioned":[],"entities":[{"asset_class":"media","name":"The Guardian","relevance":"high","symbol":"","type":"publisher"},{"asset_class":"human","name":"Woman patient (unnamed)","relevance":"high","symbol":"","type":"person"},{"asset_class":"biotech_therapy","name":"Cell therapy (implied CAR-T in related headlines)","relevance":"high","symbol":"","type":"treatment"}],"event_type":"research","information_gaps":["Specific diseases among the \u201cthree deadly diseases\u201d are not stated in the provided text.","The exact cell therapy type (e.g., CAR-T target antigen, product name, conditioning regimen) is not specified in the provided text.","No details are provided on timing (when therapy occurred, how long after treatment the recovery was observed).","No clinical endpoints or measurements (e.g., remission rates, biomarkers, duration of response) are included in the provided text.","Whether this is a peer-reviewed study, a clinical trial, or a single anecdotal case is not confirmed from the provided excerpt."],"key_facts":["The Guardian headline states the woman had a \u201cremarkable\u201d recovery after cell therapy.","The woman is described as having three deadly diseases (specific diseases not provided in the provided text).","The provided content does not include trial size, disease names, or quantitative outcomes; it is framed as a recovery/case-level result."],"numeric_claims":[],"primary_claim":"A woman with three deadly diseases had a \u201cremarkable\u201d recovery after cell therapy, according to The Guardian.","relevance_score":0.62,"sentiment":"positive","source_quality":"high","summary":"The Guardian reports a case in which a woman with three deadly diseases experienced a \u201cremarkable\u201d recovery after receiving cell therapy (described as cell therapy/CAR-T in related coverage). The near-term takeaway is positive for autoimmune/cell-therapy research, but it is presented as a single patient outcome rather than broad clinical proof.","topics":["cell therapy","CAR-T","autoimmune disease","case report","medical research"]},"source":"The Guardian","source_domain":"theguardian.com","source_url":"https://www.theguardian.com","summary":"Woman with three deadly diseases has \u2018remarkable\u2019 recovery after cell therapy The Guardian The Biggest Hope for Curing Autoimmune Disease The Atlantic 5 years after lupus breakthrough, CAR-T is still surprising autoimmunity researchers statnews.com Could cancer treatment be the key to curing autoimmune diseases? WGRZ CAR T-cell therapy takes woman from bedridden to 'perfectly fine' New Scientist","title":"Woman with three deadly diseases has \u2018remarkable\u2019 recovery after cell therapy - The Guardian","url":"https://www.gstatic.com/_/mss/boq-dots/_/ss/k=boq-dots.DotsSplashUi_desktop_ms.OYgPNdDf9Nc.L.X.O/am=GAIFAAAADpgFDCgAAQ/d=1/ed=1/rs=ALs0n2OYSmDAUDetpsORI83j3dpsv55GJQ/m=syndicationarticleview,_b,_tp"}... |